TrialAdvances in therapy2022

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension.

Rogério Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.